Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

39.76%

Threshold

Crossed downwards

Timeline

Published

03.08.2023

Transaction

25.07.2023

Voting rights breakdown

Voting rights acquired15.94%
Voting rights sold39.76%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAN7S00038

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

Regarding certain sale positions

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open